2002Chinese Journal of Laboratory DiagnosisRequires access

The expression and clinical significance of lung resistance protein gene in acute leukemia

Chao Zuo

Open publisher page 0 citations

Abstract

Objective To determine the expression of LRP gene in acute leukemia patients and evaluate the relationship between LRP expression and multidrug resistance and prognosis.Methods Expression of LRP mRNA were determined in bone marrow cells from 47 patients and 7 normal subjects by semi quantitative reverse transcription polymerase chain reaction(RT PCR).Results Expression of LRP was negative in 7 normal subjects and was positive in 17 of 25 patients with acute myelocytic leukemia, in 1 of 12 patients with acute lymphocytic leukemia and 8 of 10 refractory or relapsed patients.An analysis demonstrated LRPmRNA level was significantly higher in newly diagnosed acute myeloid leukemia and refractory or relapsed patients than in normal subjects( P = 0.001 ),increased LRPmRNA level had correlation with lower sensitivity to initial chemotherapy with reduced overall survival rate ( P 0.05).Complete remission(CR)rate was lower in LRP positive patients(3/11)than in negative patients(4/5). Conclusion The expression of LRPmRNA could predict the treatment outcome and prognosis in acute myeloid leukemia. LRP was an important resistance factor and its determination could help us design chemotherapy project.

About this research paper

What this paper is about

Objective To determine the expression of LRP gene in acute leukemia patients and evaluate the relationship between LRP expression and multidrug resistance and prognosis.Methods Expression of LRP mRNA were determined in bone marrow cells from 47 patients and 7 normal subjects by semi quantitative reverse transcription polymerase chain reaction(RT PCR).Results Expression of LRP was negative in 7 normal subjects and was positive in 17 of 25 patients with acute myelocytic leukemia, in 1 of 12 patients with acute lymphocytic leukemia and 8 of 10 refractory or relapsed patients.An analysis demonstrated LRPmRNA level was significantly higher in newly diagnosed acute myeloid leukemia and refractory or relapsed patients than in normal subjects( P = 0.001 ),increased LRPmRNA level had correlation with lower sensitivity to initial chemotherapy with reduced overall survival rate ( P 0.05).Complete remission(CR)rate was lower in LRP positive patients(3/11)than in negative patients(4/5). Conclusion The expression of LRPmRNA could predict the treatment outcome and prognosis in acute myeloid leukemia. LRP was an important resistance factor and its determination could help us design chemotherapy project.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To determine the expression of LRP gene in acute leukemia patients and evaluate the relationship between LRP expression and multidrug resistance and prognosis.Methods Expression of LRP mRNA were determined in bone marrow cells from 47 patients and 7 normal subjects by semi quantitative reverse transcription polymerase chain reaction(RT PCR).Results Expression of LRP was negative in 7 normal subjects and was positive in 17 of 25 patients with acute myelocytic leukemia, in 1 of 12 patients with acute lymphocytic leukemia and 8 of 10 refractory or relapsed patients.An analysis demonstrated LRPmRNA level was significantly higher in newly diagnosed acute myeloid leukemia and refractory or relapsed patients than in normal subjects( P = 0.001 ),increased LRPmRNA level had correlation with lower sensitivity to initial chemotherapy with reduced overall survival rate ( P 0.05).Complete remission(CR)rate was lower in LRP positive patients(3/11)than in negative patients(4/5). Conclusion The expression of LRPmRNA could predict the treatment outcome and prognosis in acute myeloid leukemia. LRP was an important resistance factor and its determination could help us design chemotherapy project.

Key concepts: Myeloid leukemia, Medicine, Chemotherapy, Leukemia, Refractory (planetary science), Acute leukemia, Internal medicine, Induction chemotherapy

Related papers

Back to paper searchBrowse research topicsOriginal source
The expression and clinical significance of lung resistance protein gene in acute leukemia — Research Paper | ScholarLens